Civic Intelligence

California Oncology Research

EIN 42-1757010 • 501(c)3 • Santa Monica, CA

Profile

Mission - The California Oncology Research Institute is committed to curing cancer through educating communities, ensuring access to early detection screenings and fostering innovative research and treatments. We care about establishing relationships within Los Angeles' underserved neighborhoods to provide information about several types of cancers.

2632 Wilshire Blvd Box 383Santa Monica, CA 90403

corigroup.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

19th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Liabilities / Revenue

20th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Net Margin

13th percentile

-23%

Higher net margin than 13% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Top Officer Pay

40th percentile

$0

Higher top officer pay than 40% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Asset Growth

60th percentile

7.2%

Faster asset growth than 60% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Revenue Growth

1st percentile

-84%

Faster revenue growth than 1% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets19th percentile

Assets

Up

$3,440,161

Up $232,384 (+7.2%) from 2023

Liabilities

Flat

$0

Flat from 2023

Net Assets

Up

$3,440,161

Up $232,384 (+7.2%) from 2023

Operations
Liabilities / Revenue20th percentileNet Margin13th percentile

Revenue

Down

$280,342

Down $1,461,768 (-84%) from 2023

Expenses

Down

$345,019

Down $10,096 (-2.8%) from 2023

Net Income

Down

-$64,677

Down $1,451,672 (-105%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth60th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$4.0M$3.0M$2.0M$1.0M$0Assets 2010: $501,848Liabilities 2010: $5,444Net Assets 2010: $496,4042010Assets 2011: $631,121Liabilities 2011: $12,744Net Assets 2011: $618,3772011Assets 2012: $753,163Liabilities 2012: $0Net Assets 2012: $753,1632012Assets 2013: $716,569Liabilities 2013: $0Net Assets 2013: $716,5692013Assets 2014: $884,768Liabilities 2014: $0Net Assets 2014: $884,7682014Assets 2015: $794,659Liabilities 2015: $0Net Assets 2015: $794,6592015Assets 2016: $631,170Liabilities 2016: $0Net Assets 2016: $631,1702016Assets 2017: $911,160Liabilities 2017: $0Net Assets 2017: $911,1602017Assets 2018: $883,646Liabilities 2018: $0Net Assets 2018: $883,6462018Assets 2019: $943,225Liabilities 2019: $0Net Assets 2019: $943,2252019Assets 2020: $988,460Liabilities 2020: $0Net Assets 2020: $988,4602020Assets 2021: $1,909,366Liabilities 2021: $0Net Assets 2021: $1,909,3662021Assets 2022: $1,678,553Liabilities 2022: $0Net Assets 2022: $1,678,5532022Assets 2023: $3,207,777Liabilities 2023: $0Net Assets 2023: $3,207,7772023Assets 2024: $3,440,161Liabilities 2024: $0Net Assets 2024: $3,440,1612024

Highlighted filing

2024

Assets$3,440,161
Liabilities$0
Net Assets$3,440,161
Open 2024 Filing

Operations Trend

Revenue Growth1st percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$2.0M$1.5M$1.0M$500K$0-$500KExpenses 2010: $288,5442010Revenue 2011: $453,666Expenses 2011: $331,693Net Income 2011: $121,9732011Expenses 2012: $229,4602012Revenue 2013: $291,519Expenses 2013: $178,113Net Income 2013: $113,4062013Revenue 2014: $328,987Expenses 2014: $260,788Net Income 2014: $68,1992014Revenue 2015: $344,000Expenses 2015: $434,109Net Income 2015: -$90,1092015Revenue 2016: $316,540Expenses 2016: $480,029Net Income 2016: -$163,4892016Revenue 2017: $454,359Expenses 2017: $174,369Net Income 2017: $279,9902017Revenue 2018: $250,399Expenses 2018: $277,913Net Income 2018: -$27,5142018Revenue 2019: $269,376Expenses 2019: $210,096Net Income 2019: $59,2802019Revenue 2020: $346,083Expenses 2020: $300,848Net Income 2020: $45,2352020Revenue 2021: $1,125,025Expenses 2021: $267,115Net Income 2021: $857,9102021Revenue 2022: $307,802Expenses 2022: $338,235Net Income 2022: -$30,4332022Revenue 2023: $1,742,110Expenses 2023: $355,115Net Income 2023: $1,386,9952023Revenue 2024: $280,342Expenses 2024: $345,019Net Income 2024: -$64,6772024

Highlighted filing

2024

Revenue$280,342
Expenses$345,019
Net Income-$64,677
Open 2024 Filing

Filings

Most recent year

2024 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$3,440,161
Liabilities
$0
Net assets
$3,440,161
Revenue
$280,342
Expenses
$345,019
Net income
-$64,677
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$3.44$0.00$3.44$0.28$0.35$0.06
2023Detailed filing. Detailed filing data is available for this year.$3.21$0.00$3.21$1.74$0.36$1.39
2022Detailed filing. Detailed filing data is available for this year.$1.68$0.00$1.68$0.31$0.34$0.03
2021Detailed filing. Detailed filing data is available for this year.$1.91$0.00$1.91$1.13$0.27$0.86
2020Detailed filing. Detailed filing data is available for this year.$0.99$0.00$0.99$0.35$0.30$0.05
2019Detailed filing. Detailed filing data is available for this year.$0.94$0.00$0.94$0.27$0.21$0.06
2018Detailed filing. Detailed filing data is available for this year.$0.88$0.00$0.88$0.25$0.28$0.03
2017Detailed filing. Detailed filing data is available for this year.$0.91$0.00$0.91$0.45$0.17$0.28
2016Detailed filing. Detailed filing data is available for this year.$0.63$0.00$0.63$0.32$0.48$0.16
2015Detailed filing. Detailed filing data is available for this year.$0.79$0.00$0.79$0.34$0.43$0.09
2014Detailed filing. Detailed filing data is available for this year.$0.88$0.00$0.88$0.33$0.26$0.07
2013Detailed filing. Detailed filing data is available for this year.$0.72$0.00$0.72$0.29$0.18$0.11
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.75$0.00$0.75$0.23
2011Summary only. Only limited summary data is available for this year.$0.63$0.01$0.62$0.45$0.33$0.12
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.50$0.01$0.50$0.29
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Nov 13, 2025
Return Version
2024v5.2
Gross Receipts
$412,006
Mission and Program Overview

Mission

The specific purpose is to support medical research in the field of oncology and conduct community outreach educational activities in underserved populations related to the screening and prevention of cancer. To further its purpose, the corporation conducts research to develop and advance methodologies for diagnosis, treatment and cure of cancer. In addition, the corporation supports other organizations conducting cancer research, gives lectures on the subject of cancer diagnosis and treatment, and disseminates information to the general public. Further, the corporation accepts contributions and makes contributions to promote the furtherance of medical research.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$2,934,797$3,359,726▲ $424,929
Cash and Non-Interest-Bearing Accounts$272,980$80,435▼ $192,545
Savings and Temporary Cash Investments-$0-
Accounts Receivable-$0-
Other Notes and Loans Receivable, Net-$0-
Pledges and Grants Receivable-$0-
Receivable From Disqualified Prsn-$0-
Receivables From Officers Etc-$0-
Investments Other Securities-$0-
Investments Program Related-$0-
Land, Buildings, and Equipment, Net-$0-
Intangible Assets-$0-
Inventories for Sale or Use-$0-
Prepaid Expenses and Deferred Charges-$0-
Total Assets$3,207,777$3,440,161▲ $232,384
Other Assets Total-$0-
Liabilities
Total Liabilities$0$0→ $0
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$2,691,263$2,923,647▲ $232,384
Net Assets With Donor Restrictions$516,514$516,514→ $0
Total Net Assets Fund Balance$3,207,777$3,440,161▲ $232,384
Total Liabilities and Net Assets / Fund Balance$3,207,777$3,440,161▲ $232,384

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings-$17,183$17,183
Equipment-$9,345$9,345
Compensation and Service Providers
Top Officer Pay40th percentile

Board Members and Trustees

NameTitle
Jonathan JacobsPresident
Joyce Eisenberg-KeeferVice President
Nicholas ThackerDirector
Anton Bilchik MdSecretary
Revenue and Support

Revenue Composition

Contributions and Grants
$200,532
Program Service Revenue
$0
Investment Income
$79,810
Other Revenue
$0
All Other Contributions
$200,532
Change in Net Assets
$-64,677
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$245,019
Grants and Similar Amounts Paid$100,000
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$100,000--$100,000
Fees for Service Investment Mgmnt Fees-$20,355-$20,355
All Other Expenses$5,395$274-$5,669
Office Expenses$4,800--$4,800
Advertising$4,547--$4,547
Insurance$4,241--$4,241
Fees for Services Accounting-$3,690-$3,690
Other Expenses$3,654--$3,654
Total Functional Expenses$320,700$24,319$0$345,019
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Receivables from Disqualified Persons-$0-
Receivables from Officers, Directors, Trustees, and Key Employees-$0-
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
No
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 2

“Deanro Inc. which receives research money from CORI is more than 35% owned by Dr. Anton Bilchik, MD, an officer and director.”

Form 990, Part VI, Section B, Line 11B

“Form 990 is reviewed by the Board of Directors prior to filing with the IRS.”

Form 990, Part VI, Section C, Line 19

“The organization does not make its governing documents, policies, or financial statements to the public as such disclosure is not required.”

Filing and Contact Details

Filer

Filer Name
California Oncology Research
EIN
42-1757010
Phone
3108830096
Address
2632 Wilshire Blvd Box 383, SANTA MONICA, CA 90403

Signing Officer

Name
Jonathan Jacobs
Title
President
Signed
2025-11-13
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Jonathan Jacobs
Formed
2008
Legal Domicile
CA
Voting Board Members
4
Independent Board Members
4
Employees
0
Volunteers
25

Preparer

Firm
Clumeck Stern Schenkelberg & Getzoff
Address
17404 Ventura Bl 2nd Floor, Encino, CA 91316
Preparer
Stephen N Getzoff
Phone
8189062230
Raw XML Appendix378 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsReceivableGrp/EOYAmt00
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0The specific purpose is to support medical research in the field of oncology and conduct community outreach educational activities in underserved populations related to the screening and prevention of cancer. To further its purpose, the corporation conducts research to develop and advance methodologies for diagnosis, treatment and cure of cancer. In addition, the corporation supports other organizations conducting cancer research, gives lectures on the subject of cancer diagnosis and treatment, and disseminates information to the general public. Further, the corporation accepts contributions and makes contributions to promote the furtherance of medical research.
IRS990/AdvertisingGrp/ProgramServicesAmt04547
IRS990/AdvertisingGrp/TotalAmt04547
IRS990/AllOtherContributionsAmt0200532
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt0274
IRS990/AllOtherExpensesGrp/ProgramServicesAmt05395
IRS990/AllOtherExpensesGrp/TotalAmt05669
IRS990/AnnualDisclosureCoveredPrsnInd0false
IRS990/BackupWthldComplianceInd0true
IRS990/BenefitsToMembersGrp/TotalAmt00
IRS990/BooksInCareOfDetail/PersonNm0ANTON BILCHIK MD
IRS990/BooksInCareOfDetail/PhoneNum03108830096
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt02632 Wilshire Blvd Box 383
IRS990/BooksInCareOfDetail/USAddress/CityNm0SANTA MONICA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd090403
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0272980
IRS990/CashNonInterestBearingGrp/EOYAmt080435
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt00
IRS990/CompDisqualPersonsGrp/TotalAmt00
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConferencesMeetingsGrp/TotalAmt00
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0200532
IRS990/CYGrantsAndSimilarPaidAmt0100000
IRS990/CYInvestmentIncomeAmt079810
IRS990/CYOtherExpensesAmt0245019
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-64677
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0345019
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0280342
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/TotalAmt00
IRS990/Desc0Three Main Goals:a) Cancer Researchb) Outreach and Education c) Artificial Intelligence (AI)and d) Legacy planningExpansion of Clinical Research: The CORI doctors have the expertise, track record, and enthusiasm to continue the excellence in clinical research through federal- and industry-funded clinical trials. However, an expanded infrastructure is necessary to maintain this effort and allow for CORI to meet its outstanding potential. The expansion requires additional personnel to facilitate industry trial identification, development and negotiation of trial budgets and contracts, assistance in establishing and documenting protocols. Investment in the clinical infrastructure in the near future would allow expansion of the program. Trainees and Researchers: CORI has supported the research of leading clinicians, young researchers and educators leading to national presentations and publications in peer-review journals. All publications have and will continue to acknowledge CORI as a source of funding.Expanding Community Outreach Activities and Educational Programs: CORI intends to offer at least three cancer educational workshops and cancer screening programs to underserved communities including inner city churches throughout the greater Los Angeles area, expand the cancer screening program to include prostate and colorectal screenings, build new partnerships with other cancer awareness and/or similar cancer organizations and increase our cancer educational literature that is offered at each cancer workshop.Strategic Alliances: Given the significant financial constraints of government funded research in the areas of clinical trials, genomic sequencing and other areas of clinical and translational research, as well as to sustain the support of trainees, strong strategic partners are needed. There may be opportunities to expand existing alliances by strengthening relationships with strategic collaborators and philanthropic organizations. These include major universities in the US and Israel as well as respected foundations such as Stand up to Cancer, the American Cancer Society, Providence Health System and Cancer Support Community.Artificial Intelligence (AI) personalize cancer care (see details below)Legacy Planning: Establish legacy planning as part of its philanthropyTranslational Lab Research: Colorectal Progress Report Perform translational multi-omics on colorectal cancer (CRC) research in early onset (EOCRC) versus late onset (LOCRC) patients to better understand the cause of EOCRC and identify potential targets for treatment.Epidemiology of Early-onset colorectal cancer(EOCRC)The incidence of early-onset colorectal cancer (EOCRC), defined as diagnosis before the age of 50, is on the rise globally, in contrast to the decreasing trend in late-onset colorectal cancer (LOCRC). Since the 1990s, the incidence of EOCRC has increased by2% annually, particularly in Western countries such as North America and Western Europe. While the exact causes remain unknown, environmental demographic factors such as dietary changes, obesity, lack of physical activity, and antibiotic use are thought to play a role. EOCRC patients are also often diagnosed at advanced clinical stages (III or IV) because they are not typically targeted for routine screening, and their symptoms can be mistaken for other colon related benign conditions such as irritable bowel syndrome. The prognosis for EOCRC is poorer than for LOCRC at the same stage, due to the more aggressive biological nature of these tumors. The purpose of this study is to elucidate potential molecular pathogenic mechanisms of EOCRC which may lead to earlier diagnosis and potential targets for therapy.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt0516514
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt0516514
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0320700
IRS990/FamilyOrBusinessRlnInd0true
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt03690
IRS990/FeesForServicesAccountingGrp/TotalAmt03690
IRS990/FeesForServicesLegalGrp/TotalAmt00
IRS990/FeesForServicesLobbyingGrp/TotalAmt00
IRS990/FeesForServicesManagementGrp/TotalAmt00
IRS990/FeesForServicesOtherGrp/TotalAmt00
IRS990/FeesForServicesProfFundraising/TotalAmt00
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt020355
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt020355
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignGrantsGrp/TotalAmt00
IRS990/ForeignOfficeInd0false
IRS990/Form1098CFiledInd0false
IRS990/Form8282FiledCnt00
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form8899Filedind0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt00.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt20.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt30.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt07.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/PersonNm0ANTON BILCHIK MD
IRS990/Form990PartVIISectionAGrp/PersonNm1Jonathan Jacobs
IRS990/Form990PartVIISectionAGrp/PersonNm2Nicholas Thacker
IRS990/Form990PartVIISectionAGrp/PersonNm3Joyce Eisenberg-Keefer
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/TitleTxt0Secretary
IRS990/Form990PartVIISectionAGrp/TitleTxt1President
IRS990/Form990PartVIISectionAGrp/TitleTxt2Director
IRS990/Form990PartVIISectionAGrp/TitleTxt3Vice President
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02008
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GainOrLossGrp/SecuritiesAmt0-8976
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt04
IRS990/GrantAmt0200532
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt00
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0100000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0100000
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt0122688
IRS990/GrossReceiptsAmt0412006
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IncmFromInvestBondProceedsGrp/TotalRevenueColumnAmt00
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt04
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/TotalAmt00
IRS990/InsuranceGrp/ProgramServicesAmt04241
IRS990/InsuranceGrp/TotalAmt04241
IRS990/IntangibleAssetsGrp/EOYAmt00
IRS990/InterestGrp/TotalAmt00
IRS990/InventoriesForSaleOrUseGrp/EOYAmt00
IRS990/InvestmentIncomeGrp/ExclusionAmt088786
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt088786
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt00
IRS990/InvestmentsProgramRelatedGrp/EOYAmt00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt02934797
IRS990/InvestmentsPubTradedSecGrp/EOYAmt03359726
IRS990/IRPDocumentCnt04
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt026528
IRS990/LandBldgEquipBasisNetGrp/EOYAmt00
IRS990/LandBldgEquipCostOrOtherBssAmt026528
IRS990/LegalDomicileStateCd0CA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt0131664
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd0false
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0Mission - The California Oncology Research Institute is committed to curing cancer through educating communities, ensuring access to early detection screenings and fostering innovative research and treatments. We care about establishing relationships within Los Angeles' underserved neighborhoods to provide information about several types of cancers.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt03207777
IRS990/NetAssetsOrFundBalancesEOYAmt03440161
IRS990/NetGainOrLossInvestmentsGrp/RelatedOrExemptFuncIncomeAmt0-8976
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-8976
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeFromGamingGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt00
IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0297061
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt02691263
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt02923647
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/TotalAmt00
IRS990/OfficeExpensesGrp/ProgramServicesAmt04800
IRS990/OfficeExpensesGrp/TotalAmt04800
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/EOYAmt00
IRS990/OtherEmployeeBenefitsGrp/TotalAmt00
IRS990/OtherExpensesGrp/Desc0RESEARCH ALLOWANCE
IRS990/OtherExpensesGrp/Desc1website/internet hosting
IRS990/OtherExpensesGrp/Desc2COMMUNITY outreach programs
IRS990/OtherExpensesGrp/Desc3RESEARCH CONFERENCES
IRS990/OtherExpensesGrp/ProgramServicesAmt0156000
IRS990/OtherExpensesGrp/ProgramServicesAmt126489
IRS990/OtherExpensesGrp/ProgramServicesAmt215574
IRS990/OtherExpensesGrp/ProgramServicesAmt33654
IRS990/OtherExpensesGrp/TotalAmt0156000
IRS990/OtherExpensesGrp/TotalAmt126489
IRS990/OtherExpensesGrp/TotalAmt215574
IRS990/OtherExpensesGrp/TotalAmt33654
IRS990/OtherRevenueTotalAmt00
IRS990/OtherSalariesAndWagesGrp/TotalAmt00
IRS990/OthNotesLoansReceivableNetGrp/EOYAmt00
IRS990/PartialLiquidationInd0false
IRS990/PaymentsToAffiliatesGrp/TotalAmt00
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/TotalAmt00
IRS990/PensionPlanContributionsGrp/TotalAmt00
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt00
IRS990/PrincipalOfficerNm0JONATHAN JACOBS
IRS990/ProfessionalFundraisingInd0false
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt01595683
IRS990/PYExcessBenefitTransInd0false
IRS990/PYGrantsAndSimilarPaidAmt0100000
IRS990/PYInvestmentIncomeAmt0146427
IRS990/PymtTravelEntrtnmntPubOfclGrp/TotalAmt00
IRS990/PYOtherExpensesAmt0255115
IRS990/PYRevenuesLessExpensesAmt01386995
IRS990/PYTotalExpensesAmt0355115
IRS990/PYTotalRevenueAmt01742110
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvblFromDisqualifiedPrsnGrp/EOYAmt00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReceivablesFromOfficersEtcGrp/EOYAmt00
IRS990/ReconcilationRevenueExpnssAmt0-64677
IRS990/RegularMonitoringEnfrcInd0false
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RoyaltiesGrp/TotalAmt00
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt00
IRS990/SavingsAndTempCashInvstGrp/EOYAmt00
IRS990ScheduleA/FactsAndCircumstancesTestTxt0Prior Year Facts and Circumstances: This organization has a history of public support both financial and non-financial since its inception in 2008. As recently as 2020, the public support percentage was 43.49%. In recent years, the support from people who are able to be included in the public support test has dropped. This is mainly due to a few large contributions to the foundation, including a $1 million dollar gift in 2021 wich was included in a total of $2 million over recent years. Due to these large gifts, the amount of gifts disallowed from the public support percentage computation is very high and, therefore, the public support percentage is lower than it has historically been. The entity is very grateful for these large gifts which have allowed them to continue the entities work in research and education of the community during the challenging fundraising period post COVID and during a trying economy.The California Oncology Research Institute exceeds the 10% public support test required by IRC Regulation 1.170A-9(3)(i) as its public support percentage for the 2024 year is 14.19%. (14.41% AND 19.74% FOR THE 2023 AND 2022 YEAR AND 21.62% for the 2021 year). The entity has added several strategic alliances and is in collaboration with St. Johns Cancer Institute (formerly John Wayne Cancer Institute) a nationally recognized organization and the Providence Health System (one of the largest non-profit health care systems in the US) Research Team working on health care diversity and population health.Both branding and the website were updated in 2022/2023 in order to gain an increase in social media presence. Followers increased by 217%, and an on-line donation platform was introduced. All events are open to the public and are held several times each year. They are well attended by the community. These events are educational in nature as community outreach is one of the missions of the organization. ATTENDANCE HAS INCREASED AT COMMUNITY EVENTS DURING THE 2023 AND 2024 YEARS AND CORI HOPES IT WILL CONTINUE TO INCREASE. SOCIAL MEDIA PLATFORMS HAVE BEEN UTILIZED MORE FREQUENTLY. ALTHOUGH THERE HAS NOT BEEN A LARGE INCREASE IN DONATIONS THROUGH THESE SOURCES THEY ALLOW THE MESSAGES AND EDUCATION PROVIDE BY THE FOUNDATION TO REACH AN EVER INCREASING AUDIENCE.
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt0200532
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01595683
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0335117
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01112760
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt0340693
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt03584785
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt088786
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt050995
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt042699
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt012265
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt05390
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0200135
IRS990ScheduleA/OtherIncome170Grp/TotalAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.14190
IRS990ScheduleA/PublicSupportPY170Pct00.14410
IRS990ScheduleA/PublicSupportTotal170Amt0537093
IRS990ScheduleA/SubstantialContributorsTotAmt03047692
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/TenPctFactsCrcmstncsTestCYInd0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt0200532
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01595683
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0335117
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01112760
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt0340693
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt03584785
IRS990ScheduleA/TotalSupportAmt03784920
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990ScheduleD/EquipmentGrp/DepreciationAmt09345
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt09345
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt017183
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt017183
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/NameOfInterested/BusinessName/BusinessNameLine1Txt0Deanro Inc
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/RelationshipDescriptionTxt035% ownership
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/SharingOfRevenuesInd0false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionDesc0Research
IRS990ScheduleL/SupplementalInformationDetail/ExplanationTxt0More than 35% of the entity is owned by A Bilchik, MD, officer and director.
IRS990ScheduleL/SupplementalInformationDetail/FormAndLineReferenceDesc0Schedule L, Part V Supplemental Information
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Deanro Inc. which receives research money from CORI is more than 35% owned by Dr. Anton Bilchik, MD, an officer and director.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Form 990 is reviewed by the Board of Directors prior to filing with the IRS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2The organization does not make its governing documents, policies, or financial statements to the public as such disclosure is not required.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990, Part VI, Section A, Line 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990, Part VI, Section B, Line 11b
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990, Part VI, Section C, Line 19
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt03207777
IRS990/TotalAssetsEOYAmt03440161
IRS990/TotalAssetsGrp/BOYAmt03207777
IRS990/TotalAssetsGrp/EOYAmt03440161
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt0200532
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt024319
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0320700
IRS990/TotalFunctionalExpensesGrp/TotalAmt0345019
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesEOYAmt00
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt00
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt03207777
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt03440161
IRS990/TotalProgramServiceExpensesAmt0320700
IRS990/TotalProgramServiceRevenueAmt00
IRS990/TotalRevenueGrp/ExclusionAmt088786
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0-8976
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0280342
IRS990/TotalVolunteersCnt025
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt03207777
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt03440161
IRS990/TravelGrp/TotalAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UponRequestInd0X
IRS990/VotingMembersGoverningBodyCnt04
IRS990/VotingMembersIndependentCnt04
IRS990/WebsiteAddressTxt0CORIGROUP.ORG
IRS990/WhistleblowerPolicyInd0true
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0Jonathan Jacobs
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-11-13
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CALIFORNIA ONCOLOGY RESEARCH
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0INSTITUTE INC
ReturnHeader/Filer/BusinessNameControlTxt0CALI
ReturnHeader/Filer/EIN0421757010
ReturnHeader/Filer/PhoneNum03108830096
ReturnHeader/Filer/USAddress/AddressLine1Txt02632 Wilshire Blvd Box 383
ReturnHeader/Filer/USAddress/CityNm0SANTA MONICA
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd090403
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0true
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0954120221
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Clumeck Stern Schenkelberg & Getzoff
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt017404 Ventura Bl 2nd Floor
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Encino
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd091316
ReturnHeader/PreparerPersonGrp/PhoneNum08189062230
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0STEPHEN N GETZOFF
ReturnHeader/ReturnTs02025-11-13T14:43:22-08:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.